Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
about
Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvantsNovel antigen delivery systems.Visual Indicators on Vaccine Boxes as Early Warning Tools to Identify Potential Freeze Damage.Micro- and nanoparticulates for DNA vaccine delivery.Reviewing the importance of the cold chain in the distribution of vaccines.Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine.Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying.Biochemical and biophysical characterization of maize-derived HBsAg for the development of an oral vaccineFormulation Studies During Preclinical Development of Influenza Hemagglutinin and Virus-Like Particle Vaccine Candidates.Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypesFactors influencing the success of aerial rabies vaccination of foxes.Developments in the formulation and delivery of spray dried vaccines.An evaluation of the cold chain technology in South-East, Nigeria using Immunogenicity study on the measles vaccines.Structural Characterization and Physicochemical Stability Profile of a Double Mutant Heat Labile Toxin Protein Based Adjuvant.A fuzzy MICMAC analysis for improving supply chain performance of basic vaccines in developing countries.Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan.Brazilian meningococcal C conjugate vaccine: physicochemical, immunological, and thermal stability characteristics.Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the NanopatchTM Microprojection Array.Principles of vaccine potency assays.Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant.On-farm storage of livestock vaccines may be a risk to vaccine efficacy: a study of the performance of on-farm refrigerators to maintain the correct storage temperature.Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach.Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display VaccinationProspects on the Use of sp. to Develop Oral VaccinesH7 Hemagglutinin nanoparticles retain immunogenicity after >3 months of 25°C storage
P2860
Q30234320-614D0472-0EBC-40FF-BFC4-09FB75C5A509Q35032554-D4E09DCC-D219-444D-8BA7-956EA8B38CBEQ35947894-C65EFED3-1A8D-4F75-9C14-FAA284F53F37Q36947820-98AEC2F7-7F65-40FC-98AB-EE67E32582FFQ37107134-E62C53E3-20D7-4A7C-A497-2AE7E9FA343BQ38595138-C7DF612C-AC7B-404E-A564-8039C20CE868Q38637680-F3B43E74-DD8A-431C-B765-8BA7ECB22E25Q38678186-E8840F2A-72AE-46D7-B3CF-C8488050DF2AQ38799025-EF5BB641-A6BE-497E-B31F-DCD9E2EAC688Q40372084-A92D3154-AB6F-4F64-ACF5-827774390A78Q40801596-740C8365-8B09-4D8A-A27F-1F899FCE75F5Q41011003-ECAC01D0-10CD-4874-9875-F325E073F1F3Q43433464-5B4D94C7-14DF-4382-B04C-1F6359731FDDQ47106090-3762EC44-5179-4ADF-94F8-6CB2E2C278C5Q47111625-CD92E782-3B31-4E0B-9FCC-69D3B05869CFQ47305690-A944B488-6590-4F7F-B6F3-951B4F14D176Q47370832-3C174C4F-4002-4F6F-AD1F-6B18582FDAFFQ47565958-4A640839-93AF-4D73-8B0D-44B8473376CBQ47774166-949CBFFB-E0E2-478C-ACFC-FB4AFF8E31C9Q48505959-C422FC8A-F888-4BDE-8701-1F2F2FDBC449Q50047834-B0B47446-64D5-4A9F-BBA5-A977B3EC9A39Q51567300-8680C8AD-FBAA-4A7F-8072-848E561004F9Q54968840-BDBA6E29-786A-4FB0-A7AE-393D9C50D53AQ55436384-570D48A9-A45F-450B-9B68-DCCA35AC0AF1Q56355788-A196B159-9255-4FEB-A1C7-B75D66604E18Q58556430-873B5EAE-C59A-4AC2-BFD9-69C0BE9385ADQ58794262-F9745AB8-4420-4074-A566-F537C4291F4F
P2860
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@ast
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@en
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@nl
type
label
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@ast
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@en
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@nl
prefLabel
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@ast
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@en
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@nl
P2093
P1433
P1476
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
@en
P2093
C. Russell Middaugh
David B. Volkin
Dawn E. Smith
Ozan S. Kumru
Sangeeta B. Joshi
Ted Prusik
P304
P356
10.1016/J.BIOLOGICALS.2014.05.007
P407
P577
2014-09-01T00:00:00Z